Avita Medical | 1811094D - Sales Revenues

Stock Price
1.17
Daily Change
-0.08 -6.40%
Monthly
-2.09%
Yearly
-61.26%
Q1 Forecast
1.23

Avita Medical reported AUD17.61M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
Celltrion KRW 1.33T 0 Mar/2026
Clinuvel Pharmaceuticals AUD 55.92M 23.66M Jun/2024
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Knight Therapeutics CAD 121.55M 14.19M Sep/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Medical Developments International AUD 21.57M 12.04M Dec/2025
Nanosonics AUD 102.23M 2.8M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Organigram Holdings CAD 80.06M 9.27M Sep/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
Pharma Mar EUR 90.2M 54.5M Dec/2025
Polynovo AUD 70.33M 35.75M Dec/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sartorius EUR 927.6M 84.4M Dec/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025
Tilray USD 217.51M 74.75M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025